Royalty Pharma Plc (RPRX): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 65,375 US Dollar | 5 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 445.277.344 | 2,92 | 4,3 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Royalty Pharma Plc
Mitarbeiter 100
Handelsplatz NASDAQ
Ticker Symbol RPRX
IPO Datum 1993-03-25
Adresse 110 East 59th Street, New York, NY, United States, 10022
Webseite https://www.royaltypharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Pablo Legorreta | Founder, Chairman of the Board & CEO |
| 2 | Mr. Terrance P. Coyne | Executive VP & CFO |
| 3 | Mr. Christopher Hite | Chairman of Partnering & Investments |
| 4 | Dr. Marshall Jonathan Urist M.D., Ph.D. | Head of Research & Investments |
| 5 | Mr. Greg Butz | Executive Vice President of Partnering & Investments |
| 6 | Mr. Eric Cornelius Schneider | Senior VP & Chief Technology Officer |
| 7 | Dr. James Folmar Reddoch Ph.D. | Executive VP of Investments & Chief Scientific Officer |
| 8 | Mr. George Grofik C.F.A., CPA | Senior VP and Head of Investor Relations & Communications |
| 9 | Mr. Arthur Richard McGivern J.D. | Executive VP of Investment & Chief Legal Officer |
| 10 | Ms. Molly Sawaya | Executive VP & Head of Human Capital |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Morgan Stanley - Brokerage Accounts | 9,64% | 3,61 Mrd. USD |
| 2 | Capital Research & Mgmt Co - Division 3 | 7,92% | 2,97 Mrd. USD |
| 3 | BlackRock Inc | 6,25% | 2,34 Mrd. USD |
| 4 | FMR Inc | 5,51% | 2,06 Mrd. USD |
| 5 | State Street Corp | 2,77% | 1,04 Mrd. USD |
| 6 | T. Rowe Price Associates, Inc. | 2,51% | 0,94 Mrd. USD |
| 7 | Swedbank AB | 2,41% | 0,90 Mrd. USD |
| 8 | Baillie Gifford & Co Limited. | 2,25% | 0,84 Mrd. USD |
| 9 | Capital World Investors | 2,14% | 0,80 Mrd. USD |
| 10 | Geode Capital Management, LLC | 1,81% | 0,68 Mrd. USD |
| 11 | Caledonia (Private) Investments Pty Ltd | 1,30% | 0,49 Mrd. USD |
| 12 | NORGES BANK | 1,20% | 0,45 Mrd. USD |
| 13 | Vanguard Capital Management, LLC | 1,08% | 0,41 Mrd. USD |
| 14 | Northern Trust Corp | 1,06% | 0,40 Mrd. USD |
| 15 | Royal London Asset Management Ltd | 0,97% | 0,36 Mrd. USD |
| 16 | AQR Capital Management LLC | 0,97% | 0,36 Mrd. USD |
| 17 | Amvescap Plc. | 0,95% | 0,36 Mrd. USD |
| 18 | Bank of America Corp | 0,93% | 0,35 Mrd. USD |
| 19 | Legal & General Group PLC | 0,85% | 0,32 Mrd. USD |
| 20 | Amundi | 0,84% | 0,31 Mrd. USD |